By a News Reporter-Staff News Editor at Biotech Business Week -- The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable experience as a Manager in Nuclear Pharmaceutical division of Cardinal Health, ranked 19(th) on the Fortune 500 list. Dr. Fu's background, which also includes a Doctor of Pharmacy degree and a Masters in Business Administration, brings a unique perspective to the marijuana industry as a whole, proving the validity of the industry as a legitimate participant in big business and a potential billion-dollar trade with major players on Wall Street (see also Biotechnology Companies).
Dr. Fu's career began as an equity partner with BioTech Pharmacy, a Nevada-based centralized nuclear pharmacy company dispensing radioactive medicine to hospitals and clinics for diagnostic and therapeutic procedures. In 2009, Biotech was purchased by Cardinal Health and Dr. Fu was asked to stay on as Manager in Nuclear Operations where Dr. Fu's direction and exemplary service include helping to establish of one of the most advanced and progressive nuclear pharmacies in the nation. Dr. Fu is also one of the few Board Certified Nuclear Pharmacists in the state of Nevada.
The MedMen's Adam Bierman, who will maintain an active role as Managing Partner of the company along with cofounder Andrew Modlin, commented, "We are elated to have Duke bring his extensive experience in business management, in particular pharmaceutical best practices, to our team. This marriage will continue to prove that The MedMen as a major force not only in the business of pot, but in big business as a whole."
Founded by entrepreneurs Bierman and Modlin, The MedMen has helped over 100 prospective marijuana business ventures through the tedious and extensive application processes for marijuana licenses and in assisting in optimizing long-term success through every aspect of operations.In early June, The MedMen found approval of all four of its cultivation and production applicants and obtained one of the 18 Special Use Permits to open a dispensary in Nevada's Unincorporated Clark County, the most competitive application process in U.S. history thus far. Currently, The MedMen is working with clients in Illinois as they prepare for applications and finalized guidelines to be announced later this year, and in Florida as its population and prospective medical marijuana operators prepare for a vote in November that will likely begin the process of legalizing medical marijuana in the state.
For press inquiries, supplementary materials, and more information on The MedMen, please visit www.TheMedMen.com or call John Filizzola (email@example.com) at (855) 292-8399.
Keywords for this news article include: The MedMen, Biotechnology Companies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC